| __timestamp | AstraZeneca PLC | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 4534000000 |
| Thursday, January 1, 2015 | 5997000000 | 5920000000 |
| Friday, January 1, 2016 | 5890000000 | 4940000000 |
| Sunday, January 1, 2017 | 5757000000 | 6411000000 |
| Monday, January 1, 2018 | 5932000000 | 6345000000 |
| Tuesday, January 1, 2019 | 5958000000 | 6148000000 |
| Wednesday, January 1, 2020 | 5991000000 | 11143000000 |
| Friday, January 1, 2021 | 9736000000 | 10195000000 |
| Saturday, January 1, 2022 | 9762000000 | 9509000000 |
| Sunday, January 1, 2023 | 10935000000 | 9299000000 |
| Monday, January 1, 2024 | 13583000000 | 11159000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, AstraZeneca PLC and Bristol-Myers Squibb Company have been at the forefront of this race. From 2014 to 2023, AstraZeneca's R&D expenses surged by nearly 96%, peaking at over $10 billion in 2023. Meanwhile, Bristol-Myers Squibb saw a 105% increase, reaching a high of approximately $11 billion in 2020.
AstraZeneca's R&D investment grew steadily, with a significant leap in 2021, reflecting its strategic focus on groundbreaking therapies. Bristol-Myers Squibb, on the other hand, experienced a dramatic spike in 2020, likely driven by its aggressive expansion into oncology and immunology. This data underscores the fierce competition and the relentless pursuit of medical breakthroughs by these pharmaceutical giants.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Bristol-Myers Squibb Company
R&D Spending Showdown: AstraZeneca PLC vs Gilead Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Neurocrine Biosciences, Inc.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Viatris Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Bristol-Myers Squibb Company and Amicus Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and HUTCHMED (China) Limited
Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Xencor, Inc.
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs BioCryst Pharmaceuticals, Inc.